§ 35-7-1014 — Substances included in Schedule I

(a) The controlled substances listed in this section are
included in Schedule I. Schedule I shall consist of the drugs
and other substances, by whatever official name, common or usual
name, chemical name or brand name designated, listed in this
section.
(b) Opiates.-Unless specifically excepted or unless listed
in another schedule, any of the following opiates, including the
isomers, esters, ethers, salts and salts of isomers, esters and
ethers, unless specifically excepted, whenever the existence of
these isomers, esters, ethers and salts is possible within the
specific chemical designation:
(i) Acetylmethadol;
(ii) Repealed By Laws 1997, ch. 151, § 2.
(iii) Allylprodine;
(iv) Alphacetylmethadol (except levo-
alphacetylmethadol also known as levo-alpha-acetylmethadol,
levomethadyl acetate, or LAAM);
(v) Alphameprodine;
(vi) Alphamethadol;
(vii) Alpha-methylfentanyl
(N-[1-(alpha-methylbeta-phenyl)ethyl-4-piperidyl]
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)
piperidine);
(viii) Benzethidine;
(ix) Betacetylmethadol;
(x) Betameprodine;
(xi) Betamethadol;
(xii) Betaprodine;
(xiii) Clonitazene;
(xiv) Dextromoramide;
(xv) Diampromide;
(xvi) Diethylthiambutene;
(xvii) Difenoxin;
(xviii) Dimenoxadol;
(xix) Dimepheptanol;
(xx) Dimethylthiambutene;
(xxi) Dioxaphetyl butyrate;
(xxii) Dipipanone;
(xxiii) Ethylmethylthiambutene;
(xxiv) Etonitazene;
(xxv) Etoxeridine;
(xxvi) Furethidine;
(xxvii) Hydroxypethidine;
(xxviii) Ketobemidone;
(xxix) Levomoramide;
(xxx) Levophenacylmorphan;
(xxxi) Morpheridine;
(xxxii) Noracymethadol;
(xxxiii) Norlevorphanol;
(xxxiv) Normethadone;
(xxxv) Norpipanone;
(xxxvi) Phenadoxone;
(xxxvii) Phenampromide;
(xxxviii) Phenomorphan;
(xxxix) Phenoperidine;
(xl) Piritramide;
(xli) Proheptazine;
(xlii) Properidine;
(xliii) Propiram;
(xliv) Racemoramide;
(xlv) Tilidine;
(xlvi) Trimeperidine;
(xlvii) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-
2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
(xlviii) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(xlix) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
phenethyl)-4-piperidinyl]-N-phenylpropanamide);
(l) Beta-hydroxy-3-methylfentanyl (other name: N-[1-
(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-
phenylpropanamide);
(li) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-
4-piperidyl]-N-phenylpropanamide);
(lii) 3-Methylthiofentanyl (N-[3-methyl-1-(2-
thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(liii) MPPP (1-methyl-4-phenyl-4-
propionoxypiperidine);
(liv) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-
(2-phenethyl)-4-piperidinyl] propanamide);
(lv) PEPAP (1-(-2-phenethyl)-4-phenyl-4-
acetoxypiperidine);
(lvi) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-
piperidinyl]-propanamide).
(c) Opium derivatives.-Unless specifically excepted or
unless listed in another schedule, any of the following opium
derivatives, their salts, isomers and salts of isomers whenever
the existence of these salts, isomers and salts of isomers is
possible within the specific chemical designation:
(i) Acetorphine;
(ii) Acetyldihydrocodeine;
(iii) Benzylmorphine;
(iv) Codeine methylbromide;
(v) Codeine-N-Oxide;
(vi) Cyprenorphine;
(vii) Desomorphine;
(viii) Dihydromorphine;
(ix) Drotebanol;
(x) Etorphine (except hydrochloride salt);
(xi) Heroin;
(xii) Hydromorphinol;
(xiii) Methyldesorphine;
(xiv) Methyldihydromorphine;
(xv) Morphine methylbromide;
(xvi) Morphine methylsulfonate;
(xvii) Morphine-N-Oxide;
(xviii) Myrophine;
(xix) Nicocodeine;
(xx) Nicomorphine;
(xxi) Normorphine;
(xxii) Pholcodine;
(xxiii) Thebacon.
(d) Hallucinogenic substances.-Unless specifically
excepted or unless listed in another schedule, any material,
compound, mixture or preparation which contains any quantity of
the following hallucinogenic substances, their salts, isomers
and salts of isomers whenever the existence of these salts,
isomers and salts of isomers is possible within the specific
chemical designation (for purposes of this paragraph only, the
term "isomer" includes the optical, position and geometric
isomers):
(i) 4-bromo-2, 5-dimethoxyamphetamine; some trade or
other names: 4-bromo-2,
5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA;
(ii) 2, 5-dimethoxyamphetamine; some trade or other
names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA;
(iii) 4-methoxyamphetamine; some trade or other
names: 4-methoxy-alpha-methylphenethylamine;
paramethoxy-amphetamine; PMA;
(iv) 5-methoxy-3,4-methylenedioxy amphetamine;
(v) 4-methyl-2, 5-dimethoxyamphetamine; some trade
and other names:
4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; "DOM"; and
"STP";
(vi) 3,4-methylenedioxy amphetamine;
(vii) 3,4,5-trimethoxy amphetamine;
(viii) Bufotenine; some trade and other names:
3-(beta-dimethy-laminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin;
5-hydroxy-N, N-dimethyltryptamine; mappine;
(ix) Diethyltryptamine; some trade and other names:
N,N-diethyltryptamine; DET;
(x) Dimethyltryptamine; some trade or other names:
DMT;
(xi) Ibogaine; some trade and other names:
7-ethyl-6,6 beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,
9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole;
tabernanthe iboga;
(xii) Lysergic acid diethylamide;
(xiii) Marihuana;
(xiv) Mescaline;
(xv) Parahexyl; some trade or other names;
3-hexyl-1-hydroxy 7, 8, 9, 10-tetrahydro-6, 6,
9-trimethyl-6H-dibenzo [b,d] pyran; synhexyl;
(xvi) Peyote; meaning all parts of the plant
presently classified botanically as Lophophora Williamsii
Lemaire, whether growing or not, the seeds thereof, any extract
from any part of such plant, and every compound, manufacture,
salts, derivative, mixture, or preparation of such plant, its
seeds or extracts;
(xvii) N-ethyl-3-piperidyl benzilate;
(xviii) N-methyl-3-piperidyl benzilate;
(xix) Psilocybin;
(xx) Psilocyn;
(xxi) Tetrahydrocannabinols; naturally occurring or
synthetic equivalents of the substances contained in the plant
or in the resinous extractives of Cannabis, sp. and/or naturally
occurring or synthetic substances, derivatives and their isomers
with similar chemical structure and pharmacological activity
such as the following: delta 1 cis or trans
tetrahydrocannabinol and their optical isomers; delta 6 cis or
trans tetrahydrocannabinol and their optical isomers; delta 8
cis or trans tetrahydrocannabinol and their optical isomers;
delta to the 3, 4 cis or trans tetrahydrocannabinol and its
optical isomers. Since nomenclature of these substances is not
internationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions are
covered;
(xxii) Ethylamine analog of phencyclidine; some trade
or other names: N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl) ethylamine, N-(1 phenylcyclohexyl)
ethylamine, cyclohexamine, PCE;
(xxiii) Pyrrolidine analog of phencyclidine; some
trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy,
PHP;
(xxiv) Thiophene analog of phencyclidine; some trade
or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine,
2-thienyl analog of phencyclidine, TPCP, TCP;
(xxv) Alpha-ethyltryptamine; some trade or other
names: etryptamine; Monase; A-ethyl-1H-indole-3-ethanamine; 3-
(2-aminobutyl) indole; --ET; and AET;
(xxvi) 4-Bromo-2,5-dimethoxyphenethylamine; some
trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-
aminoethane; alpha-desmethyl DOB; 2C-B, nexus;
(xxvii) 2,5-Dimethoxy-4-ethylamphetamine; some trade
or other names: DOET;
(xxviii) 3,4-Methylenedioxymethamphetamine (MDMA);
(xxix) 3,4-Methylenedioxy-N-ethylamphetamine (also
known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine,
N-ethyl MDA, MDE, MDEA);
(xxx) N-hydroxy-3,4-methylenedioxyamphetamine (also
known as N-hydroxy-alpha-methyl-
3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA);
(xxxi) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some
other names: TCPy;
(xxxii) 2,5-dimethoxy-4-(n)-propylthiophenethylamine
(other name: 2C-T-7), its optical isomers, salts and salts of
isomers;
(xxxiii) Alpha-methyltryptamine; (other name: AMT);
(xxxiv) 5-methoxy-N,N-diisopropyltryptamine; (other
name: 5-MeO-DIPT), its isomers, salts and salts of isomers;
(xxxv) Salvinorin A;
(xxxvi) 3,4-Methylenedioxymethcathinone (other names:
Methylone);
(xxxvii) 3,4–Methylenedioxypyrovalerone (MDPV);
(xxxviii) 4–Methylmethcathinone (other names
Mephedrone);
(xxxix) 3–Methoxymethcathinone;
(xl) 3–Fluoromethcathinone;
(xli) 4–Fluoromethcathinone;
(xlii) Synthetic cannabinoids as follows:
(A) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
some trade or other names: HU-210;
(B) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU-
211;
(C) Any compound structurally derived from 3-(1-
napthoyl)indole, 1H-indol-3-yl-(1-naphthyl)methane, 3-(1-
napthoyl)pyrrole, 3-(phenylacetyl)indole, 3-(benzoyl)indole or
naphthylideneindene by substitution at the nitrogen atom of the
indole ring, pyrrole ring or 3-position of the indene ring by
alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-
(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl,
whether or not further substituted in the indole ring, pyrrole
ring or indene ring to any extent, and whether or not
substituted in the naphthyl or phenyl ring to any extent;
(D) Repealed By Laws 2012, Ch. 29, § 2.
(E) Any compound containing a 2-(3-
hydroxycyclohexyl)phenol structure with substitution at the 5-
position of the phenolic ring by an alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-
piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
not substituted in the cyclohexyl ring to any extent;
(F) 2,3-Dihydro-5-methyl-3-(4-
morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
naphthalenylmethanone; some trade or other names: WIN 55,212-2;
(G) [(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone]; other names: XLR-11;
(H) [(1-pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone]; other names: UR-144;
(J) 1-pentyl-8-quinolinyl ester-1H-indole-3-
carboxylic acid; other names: PB-22;
(K) 1-(5-fluoropentyl)-8-quinolinyl ester-1H-
indole-3-carboxylic acid; other names: 5F-PB-22;
(M) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-
indazole-3-carboxamide; other names: AKB48;
(N) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-
fluoropentyl)1H-indazole-3-carboxamide; other names: 5F-AKB48;
(O) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-carboxamide; other names: AB-
FUBINACA;
(P) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide; other names: ADB-PINACA;
(Q) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide; other names: AB-PINACA;
(R) N-(1-amino-3,3-dimethyl-1-oxobutan-2yl)-1-
(5-fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-ADB-
PINACA;
(S) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-
fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-AB-
PINACA;
(T) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cycl
ohexylmethyl)-1H-indazole-3-carboxamide; other names: AB–
CHMINACA;
(U) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphtha
len-1-yl)methanone; other names: THJ–2201;
(W) 1-(cyclohexylmethyl)-1H-indole-3-carboxylic
acid 8-quinolinyl ester; other names: BB-22.
(xliii) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine;
other names: 2C-E;
(xliv) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine;
other names: 2C-D;
(xlv) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine;
other names: 2C-C;
(xlvi) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine;
other names: 2C-I;
(xlvii) 2-[4-(ethylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-2;
(xlviii) 2-[4-(isopropylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-4;
(xlix) 2-(2,5-dimethoxyphenyl)ethanamine; other
names: 2C-H;
(l) 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; other
names: 2C-N;
(li) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine;
other names: 2C-P;
(lii) 4-bromo-2,5-dimethoxy-N-[(2-
methoxyphenyl)methyl]-benzeneethanamine; other names: 25B-NBOMe;
(liii) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine; other names: 25C-NBOMe or 2C-C-NBOMe;
(liv) 4-iodo-2,5-dimethoxy-N-[(2-
methoxyphenyl)methyl]-benzeneethanamine; other names: 25I-NBOMe;
(lv) 3,4-methylenedioxy-N-ethylcathinone; (other
names: ethylone).
(e) Depressants.-Unless specifically excepted or unless
listed in another schedule, any material compound, mixture or
preparation which contains any quantity of the following
substances having a depressant effect on the central nervous
system, including its salts, isomers, and salts of isomers
whenever the existence of such salts, isomers and salts of
isomers is possible within the specific chemical designation:
(i) Mecloqualone;
(ii) Methaqualone;
(iii) Gamma-hydroxybutyric (some other names include
GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic
acid; sodium oxybate; sodium oxybutyrate).
(f) Stimulants.-Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following
substances having a stimulant effect on the central nervous
system, including its optical, positional, and geometric
isomers, salts and salts of isomers:
(i) Fenethylline;
(ii) N-ethylamphetamine;
(iii) Aminorex; some other names: aminoxaphen; 2-
amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2-
oxazolamine;
(iv) Cathinone; some trade or other names: 2-amino-1-
phenyl-1-propanone, alpha-aminopropiophenone, 2-
aminopropiophenone, and norephedrone;
(v) Methcathinone; some other names: 2-(methylamino)-
propiophenone; alpha-(methylamino)propiophenone; 2-
(methylamino)-1-phenylpropan-1-one; alpha-N-
methylaminopropiophenone; monomethylpropion; ephedrone; N-
methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and
UR1432), its salts, optical isomers and salts of optical
isomers;
(vi) (()Cis-4-methylaminorex ((()cis-4,5-dihydro-4-
methyl-5-phenyl-2-oxazolamine);
(vii) N,N-dimethylamphetamine (also known as N,N-
alpha-trimethyl-benzeneethanamine; N,N-alpha-
trimethylphenethylamine);
(viii) N-Benzylpiperazine; (some other names: BZP, 1-
benzylpiperazine), its optical isomers, salts and salts of
isomers;
(ix) 4-methyl-N-ethylcathinone; other names: 4-MEC;
2-(ethylamino)-1-(4-methylphenyl)propan-1-one;
(x) 4-methyl-alpha-pyrrolidinopropiophenone; other
names: 4-MePPP; MePPP;
1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one;
(xi) Alpha-pyrrolidinopentiophenone; other names:
alpha-PVP;
alpha-pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pent
an-1-one;
(xii) Butylone; other names: bk-MBDB;
1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one;
(xiii) Pentedrone; other names:
alpha-methylaminovalerophenone;
2-(methylamino)-1-phenylpentan-1-one;
(xiv) Pentylone; other names: bk-MBDP;
1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one;
(xv) Naphyrone; other names: naphthylpyrovalerone;
1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one;
(xvi) Alpha-pyrrolidinobutiophenone; other names:
alpha-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one.
(g) Temporary listing of substances subject to emergency
scheduling. Any material, compound, mixture or preparation
which contains any quantity of the following substances:
(i) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
(benzylfentanyl), its optical isomers, salts and salts of
isomers;
(ii) N-[1-(2-thienyl)methyl-4-piperidyl]-N-
phenylpropanamide (thenylfentanyl), its optical isomers, salts
and salts of isomers.